487 related articles for article (PubMed ID: 33001789)
21. The Combination of Solid-State Chemistry and Medicinal Chemistry as the Basis for the Synthesis of Theranostics Platforms.
Korolev D; Postnov V; Aleksandrov I; Murin I
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680176
[TBL] [Abstract][Full Text] [Related]
22. Theranostic Outcomes in Clinical Practice of Oncology: What, So What, Now What? What's More.
Turner JH
Cancer Biother Radiopharm; 2019 Apr; 34(3):135-140. PubMed ID: 30973278
[No Abstract] [Full Text] [Related]
23. Invited Commentary: Nuclear Theranostics-The Path Forward.
Greenspan BS; Jadvar H
Radiographics; 2020 Oct; 40(6):1741-1742. PubMed ID: 33016813
[No Abstract] [Full Text] [Related]
24. Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments.
Farolfi A; Fendler W; Iravani A; Haberkorn U; Hicks R; Herrmann K; Walz J; Fanti S
Eur Urol Oncol; 2019 Mar; 2(2):152-162. PubMed ID: 31017091
[TBL] [Abstract][Full Text] [Related]
25. Nuclear medicine and oncology.
Lind P; Gallowitsch HJ
Wien Med Wochenschr; 2012 Oct; 162(19-20):405-6. PubMed ID: 23099624
[No Abstract] [Full Text] [Related]
26. Essentials of Theranostics: A Guide for Physicians and Medical Physicists.
Sedlack AJH; Meyer C; Mench A; Winters C; Barbon D; Obrzut S; Mallak N
Radiographics; 2024 Jan; 44(1):e230097. PubMed ID: 38060426
[TBL] [Abstract][Full Text] [Related]
27. Versatile Nanosystem-Based Cancer Theranostics: Design Inspiration and Predetermined Routing.
Opoku-Damoah Y; Wang R; Zhou J; Ding Y
Theranostics; 2016; 6(7):986-1003. PubMed ID: 27217832
[TBL] [Abstract][Full Text] [Related]
28. Cancer-Associated, Stimuli-Driven, Turn on Theranostics for Multimodality Imaging and Therapy.
Li X; Kim J; Yoon J; Chen X
Adv Mater; 2017 Jun; 29(23):. PubMed ID: 28370546
[TBL] [Abstract][Full Text] [Related]
29. Theranostic applications of antibodies in oncology.
Fleuren ED; Versleijen-Jonkers YM; Heskamp S; van Herpen CM; Oyen WJ; van der Graaf WT; Boerman OC
Mol Oncol; 2014 Jun; 8(4):799-812. PubMed ID: 24725480
[TBL] [Abstract][Full Text] [Related]
30. Review on Metal-Based Theranostic Nanoparticles for Cancer Therapy and Imaging.
Fernandes DA
Technol Cancer Res Treat; 2023; 22():15330338231191493. PubMed ID: 37642945
[TBL] [Abstract][Full Text] [Related]
31. Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer.
Jiang M; Yang J; Li K; Liu J; Jing X; Tang M
Int J Med Sci; 2021; 18(3):626-638. PubMed ID: 33437197
[TBL] [Abstract][Full Text] [Related]
32. Theranostics in immuno-oncology using nanobody derivatives.
Lecocq Q; De Vlaeminck Y; Hanssens H; D'Huyvetter M; Raes G; Goyvaerts C; Keyaerts M; Devoogdt N; Breckpot K
Theranostics; 2019; 9(25):7772-7791. PubMed ID: 31695800
[TBL] [Abstract][Full Text] [Related]
33. Nanoparticle Diagnostics and Theranostics in the Clinic.
Pallares RM; Mottaghy FM; Schulz V; Kiessling F; Lammers T
J Nucl Med; 2022 Dec; 63(12):1802-1808. PubMed ID: 36302654
[TBL] [Abstract][Full Text] [Related]
34. Less Exploited GPCRs in Precision Medicine: Targets for Molecular Imaging and Theranostics.
Franco Machado J; Silva RD; Melo R; G Correia JD
Molecules; 2018 Dec; 24(1):. PubMed ID: 30583594
[TBL] [Abstract][Full Text] [Related]
35. Theranostic Pretargeting Drug Delivery and Imaging Platforms in Cancer Precision Medicine.
Hapuarachchige S; Artemov D
Front Oncol; 2020; 10():1131. PubMed ID: 32793481
[TBL] [Abstract][Full Text] [Related]
36. Alpha emitting nuclides in nuclear medicine theranostics.
Miederer M
Nuklearmedizin; 2022 Jun; 61(3):273-279. PubMed ID: 34624903
[TBL] [Abstract][Full Text] [Related]
37. Microneedle Array-Based Platforms for Future Theranostic Applications.
Howells O; Rajendran N; Mcintyre S; Amini-Asl S; Henri P; Liu Y; Guy O; Cass AEG; Morris MC; Sharma S
Chembiochem; 2019 Sep; 20(17):2198-2202. PubMed ID: 30897259
[TBL] [Abstract][Full Text] [Related]
38. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal cancers in the era of theranostics: Updates and future perspectives.
Ghosn M; Kourie HR; Tabchi S
World J Gastroenterol; 2015 Jul; 21(28):8473-7. PubMed ID: 26229391
[TBL] [Abstract][Full Text] [Related]
40. Theranostics in nuclear medicine practice.
Yordanova A; Eppard E; Kürpig S; Bundschuh RA; Schönberger S; Gonzalez-Carmona M; Feldmann G; Ahmadzadehfar H; Essler M
Onco Targets Ther; 2017; 10():4821-4828. PubMed ID: 29042793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
